Preclinical/subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences.

Volkmann, Elizabeth R; Sparks, Jeffrey A; Hoffmann-Vold, Anna-Maria; Doyle, Tracy J; Emery, Paul; Dieudé, Philippe

Volkmann, Elizabeth R; Sparks, Jeffrey A; Hoffmann-Vold, Anna-Maria; Doyle, Tracy J; Emery, Paul; Dieudé, Philippe.

Afiliación

Volkmann ER; Division of Rheumatology, Department of Medicine, University of California, Los Angeles, David Geffen School of Medicine; USA.
Sparks JA; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Hoffmann-Vold AM; Department of Rheumatology, Oslo University Hospital - Rikshospitalet, Pb 4950 Nydalen, 0424 Oslo, Norway.
Doyle TJ; Department of Rheumatology, University Hospital Zurich, University of Zurich, Switzerland, Rämistrasse 100, Zurich, Switzerland.
Emery P; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Dieudé P; Leeds NIHR Biomedical Research Centre, LTHT, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK.

Lancet Rheumatol ; 5(3): e116-e118, 2023 Mar.

Article en En | MEDLINE | ID: mdl-37701927

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Lancet Rheumatol Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google